scholarly journals Gambaran Umur, dan Jenis Kelamin Pasien Kanker Payudara di RS Ibnu Sina Kota Makassar

Author(s):  
Elma Elmika ◽  
Mateus Sakundarno Adi

Breast cancer is the most popular neither in advanced nor developing countries within case of 38 per 100,000 women. Breast cancer is still one of the health problems that occur in women in the world but does not rule out the possibility of men. This study aims to found the description of the age, and sex of breast cancer patients at Ibnu Sina Hospital Makassar. This research method was used a cross-sectional study with secondary data from medical records in 2018-2019 diagnosed with breast cancer. The data obtained of the number of annual cases, age, sex, and the number of cases that died. The results showed that in 2019, it was twice as high as 70.8% patients with a diagnosis of breast cancer, with an average age of 45-65 years, in female-dominated sex, but in this study there were 1.1 % male, the highest number of deaths occurred in 2018 with 12 cases 60.0%. The conclusion of this research is breast cancer are generally dominated from women but does not ruled out the possibility of occurring in the men, ages 45-65 who are middle-aged or elderly. So it is expected to always have a routine check as a preventative stage. Keywords: age; gender; breast cancer ABSTRAK Kanker payudara adalah kanker terbanyak di negara maju maupun negara berkembang dengan insiden 38 per 100.000 perempuan. Kanker payudara masih menjadi salah satu masalah kesehatan yang terjadi pada perempuan di dunia, namun tidak menutup kemungkinan terjadi pada laki-laki. Penelitian ini bertujuan mengetahui gambaran umur, dan jenis kelamin pasien kanker payudara di RS Ibnu Sina Makassar. Metode penelitian ini menggunakan cross-sectional dengan data sekunder rekam medis tahun 2018-2019 yang terdiagnosis kanker payudara. Data yang diperoleh yaitu jumlah kasus per tahun, umur, jenis kelamin, dan jumlah kasus meninggal. Hasil penelitian menunjukkan pada tahun 2019 dua kali lipat lebih tinggi dengan 70,8% pasien dengan terdiagnosis kanker payudara, dengan rata-rata usia 45-65 tahun, pada jenis kelamin didominasi oleh perempuan namun pada penelitian ini terdapat 1,1% berjenis kelamin laki-laki, kasus meninggal terbanyak yaitu pada tahun 2018 dengan 12 kasus 60,0%. Kesimpulan dari penelitian ini adalah kanker payudara umumnya di dominasi oleh perempuan namun tidak menutup kemungkinan terjadi pada laki-laki, usia 45-65 yang merupakan usia setengah baya atau lansia. Jadi diharapkan untuk selalu pemeriksaan rutin sebagai tahap pencegahan. Kata kunci: umur; jenis kelamin; kanker payudara

2021 ◽  
pp. 107815522110391
Author(s):  
Sujana H Chowdhury ◽  
Bilkis Banu ◽  
Nasrin Akter ◽  
Sarder M Hossain

Background Breast cancer survivor goes through a period of needs in their post-treatment daily life. Relatively few studies have been conducted to understand the unmet needs among breast cancer survivors in Bangladesh. Recognize and measure patterns and predictors of unmet needs of breast cancer patients was the aim of the study. Objective To identify and measure patterns and predictors of unmet needs of breast cancer patients in Bangladesh. Method A cross-sectional study among 138 breast cancer patients; conveniently selected from two public and two private cancer institutes. Face-to-face interview for data collection and medical record review for checklist was done. Unmet needs have been determined by the supportive care needs survey short form 34 scale. Logistic regression analyses were performed to identify the predictors of unmet needs. Results The study indicated the top 10 moderate-to-high needs; among which the top five needs were from the information need domain. Surprisingly, private cancer treatment centers were identified as a significant predictor for unmet needs. Patients from private cancer institutes reported more explanation needs as well as needs with their physical and daily living and sexuality. Furthermore, the type of treatment like patient receiving combine treatment therapy reported more need for help compared to the patient receiving chemotherapy alone. Moreover, housewives reported the low need for patient care and support systems as a result of their reluctant behavior towards their health. Conclusion Individual’s unmet need assessment should be a part of every treatment protocol of breast cancer for a better treatment outcome.


2014 ◽  
Vol 27 (1) ◽  
pp. 69-75
Author(s):  
Rosemeire Sartori de Albuquerque ◽  
Corintio Mariani Neto ◽  
Gisleine Aparecida de Castro Arone ◽  
Ana Aparecida Sanches Bersusa ◽  
Vanessa Peres Leandro

OBJECTIVE: Assess the differentiated aspiration process of palivizumab, from planning to administration, and from the patient's profile to obtained savings as a result of the optimization of doses.METHODS: Cross-sectional study carried out by means of secondary data obtained from the medical records of 858 children. Variables of the study were as follows: information on the profile of cared children, amount of acquired and administered doses, vaccination procedure, and optimized doses. Data were extracted from care management reports.RESULTS: The innovative technique and the vaccination planning allowed for 98 children to be favored by leftovers of the medication, implying savings of R$ 1.144.347,52 in 2012 and 2013.CONCLUSION: The employment of the differentiated aspiration process favored the availability of the medication to 54 children other than those previously programmed, and the application of 78 leftovers. The establishment of a previous management planning process of programmed contents to be administered to children, in compliance with their profile, especially their body weight, favored the inclusion of other admitted newborns. The systematization process of the team work toward the administration of palivizumab implied the reduction of public expenditures.


2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 22160-22160
Author(s):  
N. Raizada ◽  
H. S. Vadiraja ◽  
R. M. Raghavendra ◽  
B. S. Ajaikumar ◽  
R. S. Bilimagga ◽  
...  

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e18132-e18132
Author(s):  
Elna Kuehnle ◽  
Wulf Siggelkow ◽  
Iris Schrader ◽  
Kristina Luebbe ◽  
Stefanie Noeding ◽  
...  

e18132 Background: In 2003 the German Cancer Society and the German Society for Breast Disease introduced a number of Quality Indicators (QIs) to improve standards of breast cancer care. Although QIs should be based on clinical evidence, evidence for important subpopulations (i.e. vulnerable patients) is often limited. In this prospective cross-sectional study we assessed conformity and non-conformity of guidelines and their impact on clinical outcome in a real-world setting. Methods: This prospective analysis included patients with primary breast cancer. Patients with stage IV and recurrent breast cancer were excluded. Data was collected from 2012-2016 in six certified breast care centers using a personal questionnaire and data from the patients' medical records. Guideline adherence to a set of 11 QIs was explored. Overall survival (OS) and disease free survival (DFS) were correlated with fulfillment of QIs and tumor characteristics. Results: Survival analysis was conducted in 2390 patients with a median follow-up of 16 months. 88 (4%) patients had a recurrent disease. 31 (1.3%) patients died of breast cancer. Tumor stage, grading, Her2- and hormone receptor status and Ki-67 correlated with DFS and OS. 1725/1907 patients (90.5%) received a guideline adherent treatment. The most prevalent reasons for non-conformity were old age (24.7%) and/or comorbidity (20.9%). Breast cancer specific DFS and OS were not significantly different between patients treated adherent or not adherent to the guidelines. In contrast, survival analysis of death other than breast cancer showed a significantly worse OS (p = 0.006) for patients not treated according to guideline recommendation. Conclusions: Conformity of clinical guidelines was observed in the majority of patients including healthy and vulnerable patients. These patients tended to have a longer breast cancer specific survival. Patients who were not considered suitable for guideline-adherent therapy died more often from other medical reasons rather than from breast cancer. In our study 10% of the patients had a limited life expectancy due to old age and co-morbidities with no assumed benefit from guideline adherence.


The Breast ◽  
2017 ◽  
Vol 31 ◽  
pp. 26-33 ◽  
Author(s):  
Soufiane Berhili ◽  
Selma Kadiri ◽  
Amal Bouziane ◽  
Abdallah Aissa ◽  
Elamin Marnouche ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document